Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for RARG
Z-value: 1.63
Motif logo
Transcription factors associated with RARG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RARG
|
ENSG00000172819.12 | retinoic acid receptor gamma |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RARG | hg19_v2_chr12_-_53614155_53614197, hg19_v2_chr12_-_53614043_53614154 | 0.05 | 5.0e-01 | Click! |
Activity profile of RARG motif
Sorted Z-values of RARG motif
Network of associatons between targets according to the STRING database.
First level regulatory network of RARG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.1 | 39.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 9.1 | 64.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 7.0 | 35.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 6.6 | 19.7 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 6.4 | 25.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 5.0 | 15.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 4.7 | 28.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 4.6 | 13.7 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 4.5 | 13.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 4.5 | 81.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 4.5 | 49.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 4.4 | 13.2 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 4.4 | 17.4 | GO:0009956 | radial pattern formation(GO:0009956) |
| 4.2 | 25.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 4.1 | 20.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 4.1 | 16.4 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 3.9 | 15.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 3.8 | 11.5 | GO:1904647 | response to rotenone(GO:1904647) |
| 3.8 | 22.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 3.8 | 11.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 3.7 | 14.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 3.5 | 3.5 | GO:0048026 | positive regulation of RNA splicing(GO:0033120) positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 3.2 | 19.1 | GO:0030421 | defecation(GO:0030421) |
| 3.2 | 25.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 3.0 | 18.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 3.0 | 12.1 | GO:0021564 | vagus nerve development(GO:0021564) |
| 2.9 | 8.8 | GO:1900158 | negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 2.9 | 45.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 2.8 | 11.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 2.8 | 11.1 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
| 2.6 | 13.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 2.6 | 10.5 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.6 | 18.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 2.6 | 13.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 2.6 | 2.6 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 2.5 | 7.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 2.5 | 9.9 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 2.4 | 9.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 2.4 | 14.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 2.4 | 9.7 | GO:0043335 | protein unfolding(GO:0043335) |
| 2.3 | 27.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 2.2 | 11.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 2.2 | 17.8 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 2.2 | 6.6 | GO:2000276 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 2.1 | 12.8 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.1 | 12.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 2.1 | 17.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 2.1 | 20.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 2.1 | 8.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 2.0 | 2.0 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.0 | 12.1 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 2.0 | 5.9 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 2.0 | 5.9 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.9 | 40.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.9 | 11.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.9 | 3.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.8 | 27.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.8 | 5.5 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 1.8 | 21.8 | GO:0006108 | malate metabolic process(GO:0006108) |
| 1.8 | 5.4 | GO:0060086 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) circadian temperature homeostasis(GO:0060086) |
| 1.8 | 5.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.7 | 8.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 1.7 | 8.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 1.7 | 8.7 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.7 | 3.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 1.7 | 6.9 | GO:0019046 | release from viral latency(GO:0019046) |
| 1.7 | 13.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 1.6 | 6.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 1.6 | 1.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 1.6 | 11.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 1.6 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.6 | 12.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.5 | 4.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 1.5 | 4.6 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.5 | 9.2 | GO:0009624 | response to nematode(GO:0009624) |
| 1.5 | 26.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 1.5 | 13.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.4 | 4.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.4 | 11.5 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 1.4 | 2.9 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
| 1.4 | 8.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.4 | 5.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.4 | 4.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.4 | 5.5 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.4 | 6.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 1.4 | 6.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 1.3 | 4.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.3 | 4.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 1.3 | 18.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 1.3 | 4.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 1.3 | 5.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.3 | 9.2 | GO:0015677 | copper ion import(GO:0015677) |
| 1.3 | 2.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 1.3 | 7.7 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 1.3 | 29.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 1.2 | 3.7 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.2 | 2.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 1.1 | 14.9 | GO:0016559 | peroxisome fission(GO:0016559) |
| 1.1 | 8.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.1 | 4.5 | GO:0030242 | pexophagy(GO:0030242) |
| 1.1 | 18.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 1.1 | 11.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 1.1 | 8.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.1 | 5.4 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) blood vessel endothelial cell differentiation(GO:0060837) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) ganglion morphogenesis(GO:0061552) blood vessel endothelial cell fate specification(GO:0097101) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.1 | 7.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 1.1 | 2.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 1.1 | 12.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 1.1 | 5.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.1 | 63.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 1.0 | 4.2 | GO:0021539 | subthalamus development(GO:0021539) |
| 1.0 | 4.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.0 | 20.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 1.0 | 3.1 | GO:0032242 | regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
| 1.0 | 4.1 | GO:0002884 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
| 1.0 | 6.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 1.0 | 3.0 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 1.0 | 15.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 1.0 | 8.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 1.0 | 3.8 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.9 | 4.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.9 | 8.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.9 | 16.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.9 | 2.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.9 | 5.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.9 | 8.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.9 | 6.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.9 | 3.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.9 | 4.4 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.9 | 16.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.9 | 11.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 | 7.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.9 | 8.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.9 | 2.6 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.9 | 4.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.9 | 2.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.9 | 1.7 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.8 | 3.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.8 | 3.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.8 | 5.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.8 | 11.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.8 | 3.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 | 4.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.8 | 2.4 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.8 | 9.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.8 | 2.4 | GO:0002752 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.8 | 3.2 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.8 | 3.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.8 | 34.7 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.8 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.8 | 1.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.8 | 7.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.8 | 6.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.7 | 9.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.7 | 3.7 | GO:0035989 | tendon development(GO:0035989) |
| 0.7 | 5.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.7 | 3.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.7 | 3.0 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.7 | 2.2 | GO:0090521 | regulation of embryonic cell shape(GO:0016476) glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 | 1.5 | GO:0044571 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) [2Fe-2S] cluster assembly(GO:0044571) |
| 0.7 | 2.9 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.7 | 3.6 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
| 0.7 | 19.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.7 | 2.8 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.7 | 12.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.7 | 2.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.7 | 2.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.7 | 4.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.7 | 2.0 | GO:0060595 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) mammary gland specification(GO:0060594) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.7 | 1.3 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.7 | 8.1 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.7 | 2.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 | 2.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.7 | 29.7 | GO:0061718 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.7 | 9.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.7 | 3.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.6 | 3.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.6 | 3.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.6 | 2.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.6 | 1.8 | GO:1902256 | endocardial cushion fusion(GO:0003274) apoptotic process involved in outflow tract morphogenesis(GO:0003275) negative regulation of alkaline phosphatase activity(GO:0010693) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.6 | 9.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.6 | 1.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.6 | 1.8 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.6 | 11.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.6 | 13.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.6 | 9.1 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.6 | 1.7 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.6 | 1.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.6 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.5 | 1.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.5 | 6.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 | 4.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.5 | 3.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 0.5 | 4.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.5 | 2.1 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.5 | 1.6 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.5 | 2.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 | 4.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 | 1.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 | 2.5 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.5 | 2.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.5 | 4.5 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
| 0.5 | 1.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.5 | 2.0 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.5 | 2.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.5 | 15.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.5 | 11.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.5 | 0.5 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.5 | 6.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.5 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.5 | 9.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.5 | 1.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.5 | 3.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.5 | 7.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.5 | 2.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.5 | 4.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.5 | 1.8 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.5 | 11.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.5 | 4.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 0.9 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.4 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.4 | 1.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
| 0.4 | 1.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.4 | 3.0 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.4 | 3.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 0.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.4 | 1.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 0.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.4 | 2.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.4 | 1.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.4 | 2.1 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.4 | 7.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.4 | 4.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.4 | 2.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.4 | 1.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 16.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.4 | 6.5 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.4 | 2.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.4 | 6.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.4 | 2.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.4 | 2.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.4 | 2.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.4 | 6.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.4 | 6.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.4 | 1.6 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.4 | 1.6 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
| 0.4 | 11.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.4 | 5.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.4 | 1.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 1.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.4 | 3.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.4 | 20.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.4 | 3.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.4 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.4 | 9.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.4 | 7.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 | 8.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.4 | 10.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.4 | 0.7 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 | 3.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 2.1 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.4 | 1.8 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 | 1.1 | GO:0051037 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.4 | 1.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 | 2.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 | 6.2 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.3 | 1.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 2.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 | 4.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 | 4.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.3 | 3.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.3 | 5.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.3 | 0.7 | GO:0090175 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.3 | 7.6 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.3 | 3.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.3 | 7.8 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.3 | 2.3 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 1.3 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.3 | 11.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.3 | 7.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.3 | 4.8 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 1.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 3.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 | 6.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.3 | 4.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 1.9 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.3 | 3.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.3 | 9.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.3 | 6.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 8.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 | 8.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.3 | 1.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 3.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.3 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.3 | 12.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.3 | 1.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.3 | 11.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.3 | 8.9 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 3.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 2.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.3 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.3 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.3 | 1.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.3 | 2.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.3 | 3.0 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.3 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 0.8 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) intestinal epithelial cell maturation(GO:0060574) |
| 0.3 | 9.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.3 | 0.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 5.0 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.3 | 17.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.3 | 5.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.3 | 4.3 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.3 | 2.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.3 | 2.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.2 | 3.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 2.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 | 5.2 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.2 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 2.7 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.2 | 0.5 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.2 | 2.7 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 2.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 6.0 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.2 | 3.1 | GO:0035878 | nail development(GO:0035878) |
| 0.2 | 6.9 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 | 2.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 | 1.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 | 4.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 3.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.2 | 3.7 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 | 10.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 8.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 | 0.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 2.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 3.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.2 | 1.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 | 2.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 2.0 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.2 | 17.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.2 | 0.7 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 1.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 15.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
| 0.2 | 10.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.2 | 6.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.2 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 3.0 |